Distinguished in Ulcerative Colitis

Dr. Frank Hoentjen

Gastroenterology
5841 S Maryland Ave, Room M226(mc4076), 
Chicago, IL 
Distinguished in Ulcerative Colitis
5841 S Maryland Ave, Room M226(mc4076), 
Chicago, IL 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Frank Hoentjen is a Gastroenterologist in Chicago, Illinois. Dr. Hoentjen is rated as a Distinguished provider by MediFind in the treatment of Ulcerative Colitis. His top areas of expertise are Viral Gastroenteritis, Colitis, Crohn's Disease, Endoscopy, and Colonoscopy.

His clinical research consists of co-authoring 173 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 55 articles in the study of Ulcerative Colitis.

Specialties
Gastroenterology
Licenses
Internal Medicine in IL
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

5841 S Maryland Ave, Room M226(mc4076), Chicago, IL 60637

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

An Open Label Interventional Phase 4 Study to Evaluate Efficacy, Safety and Mucosal Healing of Early Versus Late Use of Vedolizumab in Crohn's Disease: the LOVE-CD Study (LOw Countries VEdolizumab in CD Study)
An Open Label Interventional Phase 4 Study to Evaluate Efficacy, Safety and Mucosal Healing of Early Versus Late Use of Vedolizumab in Crohn's Disease: the LOVE-CD Study (LOw Countries VEdolizumab in CD Study)
Enrollment Status: Completed
Publish Date: June 23, 2023
Intervention Type: Drug
Study Drug: Vedolizumab
Study Phase: Phase 4
A Phase 2, Multicenter, Randomized, Parallel-Arm, Placebo-Controlled Study of LY3074828 in Subjects With Active Crohn's Disease (SERENITY)
A Phase 2, Multicenter, Randomized, Parallel-Arm, Placebo-Controlled Study of LY3074828 in Subjects With Active Crohn's Disease (SERENITY)
Enrollment Status: Completed
Publish Date: August 30, 2022
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 2
View 1 Less Clinical Trial

173 Total Publications

Long-term outcomes of increased versus conventional adalimumab dose interval for patients with Crohn's disease in stable remission: 3-year follow-up of the randomized controlled LADI trial.
Long-term outcomes of increased versus conventional adalimumab dose interval for patients with Crohn's disease in stable remission: 3-year follow-up of the randomized controlled LADI trial.
Journal: Gastroenterology
Published: June 23, 2025
Similar Doctors
Stephen B. Hanauer
Elite in Ulcerative Colitis
Dr. Stephen B. Hanauer
Gastroenterology
Elite in Ulcerative Colitis
Dr. Stephen B. Hanauer
Gastroenterology
259 E Erie St Ste 1600, Lavin Family Pavilion, 
Chicago, IL 
 (7.4 miles away)
312-695-5620
Experience:
48+ years
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Stephen Hanauer is a Gastroenterologist in Chicago, Illinois. Dr. Hanauer has been practicing medicine for over 48 years and is rated as an Elite provider by MediFind in the treatment of Ulcerative Colitis. His top areas of expertise are Crohn's Disease, Viral Gastroenteritis, Ulcerative Colitis, Colonoscopy, and Endoscopy.

Parambir S. Dulai
Elite in Ulcerative Colitis
Dr. Parambir S. Dulai
Gastroenterology
Elite in Ulcerative Colitis
Dr. Parambir S. Dulai
Gastroenterology
259 E Erie St Ste 1600, Lavin Family Pavilion, 
Chicago, IL 
 (7.4 miles away)
312-695-5620
Experience:
16+ years
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Parambir Dulai is a Gastroenterologist in Chicago, Illinois. Dr. Dulai has been practicing medicine for over 16 years and is rated as an Elite provider by MediFind in the treatment of Ulcerative Colitis. His top areas of expertise are Viral Gastroenteritis, Hemorrhagic Proctocolitis, Ulcerative Colitis, Endoscopy, and Colonoscopy.

Russell D. Cohen
Elite in Ulcerative Colitis
Dr. Russell D. Cohen
Gastroenterology
Elite in Ulcerative Colitis
Dr. Russell D. Cohen
Gastroenterology

The University Of Chicago

5841 S Maryland Ave, 
Chicago, IL 
 (0.1 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Russell Cohen is a Gastroenterologist in Chicago, Illinois. Dr. Cohen is rated as an Elite provider by MediFind in the treatment of Ulcerative Colitis. His top areas of expertise are Crohn's Disease, Ulcerative Colitis, Hemorrhagic Proctocolitis, Ileostomy, and Colonoscopy. Dr. Cohen is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Hoentjen's expertise for a condition
ConditionClose
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile